Author:
Sevillano David,Calvo Almudena,Giménez María-José,Alou Luis,Aguilar Lorenzo,Valero Eva,Carcas Antonio,Prieto José
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)
Reference10 articles.
1. Kaye, C. M., Allen, A., Perry, S. et al. (2001). The clinical pharmacokinetics of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate. Clinical Therapeutics23, 578–84.
2. Doern, G. V. (2001). Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States. Clinical Infectious Diseases33, Suppl. 3, S187–92.
3. National Committee for Clinical Laboratory Standards. (1992). Methods for Determining Bactericidal Activity for Antimicrobial Agents. Tentative Guideline M26-T. NCCLS, Villanova, PA, USA.
4. Blaser, J., Stone, B. B. & Zinner, S. H. (1985). Efficacy of intermittent versus continuous administration of netilmicin in a two-compartment in vitro model. Antimicrobial Agents and Chemotherapy27, 343–9.
5. Blaser, J., Stone, B. B., Groner, M. C. et al. (1987). Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and the emergence of resistance. Antimicrobial Agents and Chemotherapy31, 1054–60.
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献